Adenosine triphosphate-sensitive potassium channels are involved in insulin-mediated glucose transport in humans

Metabolism: Clinical and Experimental

Volumn 48, Issue 4, 1999, Pages 432-436

  Wasada, Taro ^a   Watanabe, Chizuru ^a   Nakagami, Tomoko ^a   Iwamoto, Yasuhiko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; NICORANDIL; POTASSIUM CHANNEL;

ADULT; ARTICLE; CELL FUNCTION; CLINICAL ARTICLE; COMPLEX FORMATION; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; HUMAN; HYPERINSULINEMIA; INSULIN RELEASE; MALE; PANCREAS ISLET BETA CELL; POTASSIUM CONDUCTANCE; PRIORITY JOURNAL; TARGET CELL;

EID: 0032916002     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(99)90099-9     Document Type: Article

References (30)

1. Smits P, Thien T: Cardiovascular effects of sulphonylurea derivatives. Implications for the treatment of NIDDM? Diabetologia 38:116-121, 1995
2. Leibowitz G, Cerasi E: Sulphonylurea treatment of NIDDM patients with cardiovascular disease: A mixed blessing? Diabetologia 39:503-514, 1996
3. Inagaki N, Gonoi T, Clement JP IV, et al: A family of sulphonylurea receptors determines the pharmacological properties of ATP-sensitive K-channels. Neuron 16:1011-1017, 1996
4. Inagaki N, Gonoi T, Clement JP IV, et al: Recognition of IK-ATP: An inward rectifier subunit plus the sulfonylurea receptor. Science 270:1166-1170, 1995
5. Chutkow WA, Simon MC, Le Beau MM, et al: Cloning, tissue expression, and chromosomal localization of SUR2, the putative drug-binding subunit of cardiac, skeletal muscle, and vascular K-ATP channels. Diabetes 45:1439-1445, 1996
6. Muller G, Wied S: The sulfonylurea drug, glimepiride, stimulates glucose transport, glucose transporter translocation, and dephosphorylation in insulin-resistant rat adipocytes in vitro. Diabetologia 42:1852-1867, 1993
7. Tsiani E, Ramlal T, Leiter LA, et al: Stimulation of glucose uptake and increased plasma membrane content of glucose transporters in L6 skeletal muscle cells by the sulfonylureas gliclazide and glyburide. Endocrinology 136:2505-2512, 1995
8. Pulido N, Casla A, Suarez A, et al: Sulphonylurea stimulates glucose uptake in rats through an ATP-sensitive K channel dependent mechanism. Diabetologia 39:22-27, 1996
9. Wasada T, Kuroki H, Naruse M, et al: Insulin resistance is associated with high plasma ouabain-like immunoreactivity concentration in NIDDM. Diabetologia 38:792-797, 1995
10. Ashcroft SJH, Ashcroft FM: Properties and functions of ATP-sensitive K channels. Cell Signal 2:197-214, 1990
11. De Weille JR, Lazdunski M: Regulation of the ATP-sensitive potassium channel. Ion Channels 2:205-222, 1990
12. Takano M, Noma A: The ATP-sensitive K channel. Prog Neurobiol 41:21-30, 1993
13. Nelson MT, Patlack JB, Worley JF, et al: Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle cell tone. Am J Physiol 259:C3-C18, 1990
14. + channels in mouse pancreatic B-cells. Br J Pharmacol 98:957-965, 1989
15. + channel openers and insulin release. Life Sci 51:795-806, 1992
16. Cooper DR, Vila MC, Watson JE, et al: Sulfonylurea-stimulated glucose transport association with diacylglycerol-like activation of protein kinase C in BC3H1 myocytes. Diabetes 39:1399-1407, 1990
17. Rogers BJ, Standaert ML, Pollet RJ: Direct effects of sulfonylurea agents on glucose transport in the BC3H1 myocyte. Diabetes 36:1292-1296, 1987
18. Maloff B, Lockwood DH: In vitro effects of a sulfonylurea on insulin action in adipocytes. Potentiation of insulin-stimulated hexose transport. J Clin Invest 68:85-90, 1981
19. Wang PH, Moller D, Flier JS, et al: Coordinate regulation of glucose transporter function, number, and gene expression by insulin and sulfonylureas in L6 rat skeletal muscle cells. J Clin Invest 84:62-67, 1989
20. Kashiwagi A, Harano Y, Suzuki M, et al: New alpha 2-adrenergic blocker (DG-5128) improves insulin secretion and in vivo glucose disposal in NIDDM patients. Diabetes 35:1085-1089, 1986
21. Zaitsev SV, Efanov AM, Efanova IB, et al: Imidazoline compounds stimulate insulin release by inhibition of K-ATP channels and interaction with the exocytotic machinery. Diabetes 45:1610-1618, 1996
22. Lee K, Ibbotson T, Richardson PJ, et al: Inhibition of K-ATP channel activity by troglitazone in CRI-Gl insulin-secreting cells. Eur J Pharmacol 313:163-167, 1996
23. Rowe ICM, Lee K, Khan RN, et al: Effect of englitazone on K-ATP and calcium-activated non-selective cation channels in CRI-G1 insulin-secreting cells. Br J Pharmacol 121:531-539, 1997
24. Youn JH, Gulve EA, Holloszy JO: Calcium stimulates glucose transport in skeletal muscle by a pathway independent of contraction. Am J Physiol 260:C555-C561, 1991
25. 2+-dependent mechanism. Diabetes 44:1345-1348, 1995
26. Clausen T, Elbrink J, Dahl-Hansen AB: The relationship between the transport of glucose and cations across cell membranes in isolated tissues. IX. The role of cellular calcium in the activation of the glucose transport system in rat soleus muscle. Biochim Biophys Acta 375:292-308, 1975
27. Xiong Z, Kajioka S, Sakai T, et al: Pinacidil inhibits the ryanodine-sensitive outward current and glibenclamide antagonizes its action in cells from the rabbit portal vein. Br J Pharmacol 102:788-790. 1991
28. Taira N: Nicorandil as a hybrid between nitrates and potassium channel activators. Am J Cardiol 63:18J-24J, 1989
29. Kapur S, Bedard S, Marcotte B, et al: Expression of nitric oxide synthase in skeletal muscle: A novel role for nitric oxide as a modulator of insulin action. Diabetes 46:1691-1700, 1997
30. Etgen GJ, Fryburg DA Jr, Gibbs EM: Nitric oxide stimulates skeletal muscle glucose transport through a calcium/contraction- and phosphatidylinositol-3-kinase-independent pathway. Diabetes 46:1915-1919, 1997